TherapeuticsMD (TXMD) Operating Income (2011 - 2026)
TherapeuticsMD's (TXMD) quarterly Operating Income came in at -$723000.0 in Q1 2026, up 43.56% YoY from -$503623.2 in Q1 2025, and up 53.41% on a QoQ basis from -$1.6 million in Q4 2025.
TherapeuticsMD (TXMD) Operating Income (2011 - 2026) Analysis & Trends
TherapeuticsMD (TXMD) has 16 years of Operating Income data on file, last reported at -$723000.0 in Q1 2026.
- Quarterly Operating Income rose 43.56% year-over-year to -$723000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.8 million (up 34.56% YoY) and the FY2025 annual result came in at -$4.4 million, up 28.17% from the prior year.
- Operating Income climbed to -$723000.0 in Q1 2026, from -$1.6 million in the prior quarter.
- In the past five years, Operating Income ranged from a high of $48.4 million in Q4 2022 to a low of -$17.9 million in Q1 2022.
- A 5-year average of -$1.1 million and a median of -$1.6 million in 2025 frame the typical range for Operating Income.
- Annual changes were most pronounced in 2022 — Operating Income soared 236.87% — and 2025, when it slumped 138.04%.
- Tracing TXMD's Operating Income over 5 years: stood at $48.4 million in 2022, then plunged by 103.33% to -$1.6 million in 2023, then jumped by 59.53% to -$652000.0 in 2024, then tumbled by 138.04% to -$1.6 million in 2025, then soared by 53.41% to -$723000.0 in 2026.
- The last three Operating Income figures came in at -$723000.0 (Q1 2026), -$1.6 million (Q4 2025), and -$862000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | TherapeuticsMD | 23.56 Mn | 14.37 Mn | - | -816,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -816,000.00 |
| Mar 31, 2026 | -723,000.00 |
| Dec 31, 2025 | -1.55 Mn |
| Sep 30, 2025 | -862,000.00 |
| Jun 30, 2025 | -695,000.00 |
| Mar 31, 2025 | -1.28 Mn |
| Dec 31, 2024 | -652,000.00 |
| Sep 30, 2024 | -1.13 Mn |
| Jun 30, 2024 | -2.79 Mn |
| Mar 31, 2024 | -1.14 Mn |
| Dec 31, 2023 | -1.61 Mn |
| Sep 30, 2023 | -1.77 Mn |
| Jun 30, 2023 | -2.47 Mn |
| Mar 31, 2023 | -2.67 Mn |
| Dec 31, 2022 | 48.44 Mn |
| Sep 30, 2022 | -14.52 Mn |
| Jun 30, 2022 | -14.86 Mn |
| Mar 31, 2022 | -17.88 Mn |
| Dec 31, 2021 | -35.39 Mn |
| Sep 30, 2021 | -39.92 Mn |